Gum Acacia and Blood Glucose

October 3, 2019 updated by: University of Minnesota

The Effect of Gum Acacia on Satiety, Glycemic Response and Gastrointestinal Tolerance

This study will provide needed insight on the satiety and blood glucose and l effects of the soluble fiber gum acacia at 20g and 40g doses.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a randomized, single-blind, crossover, intervention study testing the satiety and blood glucose effects of the soluble fiber gum acacia.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Saint Paul, Minnesota, United States, 55108
        • Department of Food Science and Nutrition

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: BMI between 18 and 29 kg/m2

Exclusion Criteria:

  • distaste for bagels and cream cheese, orange juice or cheese pizza;
  • current smoker;
  • restrained eating habits;
  • recent weight change;
  • any history of disease or significant past medical history;
  • are vegetarian;
  • do not normally eat breakfast or lunch;
  • pregnant or lactating;
  • irregular menstrual cycles.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 0 fiber
0 grams fiber added to orange juice
No acacia gum will be added to orange juice.
Experimental: low fiber
20 grams of acacia gum added to orange juice
20 g of acacia gum will be added to orange juice
Experimental: high fiber
40 grams of acacia gum added to orange juice
40 g of acacia gum will be added to orange juice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose levels
Time Frame: 0, 30, 60, 120, 180, and 240 minutes after breakfast; Area under the curve (AUC) will be calculated for each treatment
Blood will be taken via finger stick
0, 30, 60, 120, 180, and 240 minutes after breakfast; Area under the curve (AUC) will be calculated for each treatment
Appetite Sensation
Time Frame: 15, 30, 45, 60, 90, 120, 180 and 240 minutes after breakfast; Area under the curve (AUC) will be calculated for each treatment
Subjective visual analog scale (VAS) will be utilized to assess hunger, fullness and desire to eat
15, 30, 45, 60, 90, 120, 180 and 240 minutes after breakfast; Area under the curve (AUC) will be calculated for each treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2018

Primary Completion (Actual)

August 31, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

August 29, 2018

First Submitted That Met QC Criteria

October 16, 2018

First Posted (Actual)

October 23, 2018

Study Record Updates

Last Update Posted (Actual)

October 4, 2019

Last Update Submitted That Met QC Criteria

October 3, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00004203

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet Modification

Clinical Trials on Placebo/Control

3
Subscribe